~~<i id='1DED6E1FAA'><strike id='1DED6E1FAA'><tt id='1DED6E1FAA'><pre id='1DED6E1FAA'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：entertainment 2025-08-04 05:18:05 Page View：7

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Stories you might have missed in 2023: health, science, medicine
Next article： Jerome Adams on the need for new antivirals for Covid

knowledge

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

Physician assistants need a new name. Here's what it should be

AdobeI’mstandingoveranoperatingtable,excisingaskincancerfromtheforeheadofanelderlygentlemanwhilesoft

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

At JPM 2024, hospital systems pitch financial strength to investors

AdobeSANFRANCISCO—HospitalleadersspentagoodchunkoftheirstagetimeattheJ.P.MorganHealthcareConferencet